LifeScience Biotech
Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma Complements Existing...
January 03, 2023 | News
This submission is based on data from the confirmatory Phase 2 clinical study CARTIFAN-1 (NCT03758417) conducted in China, which evaluated the efficacy and...
January 03, 2023 | News
Collaboration complements Merck’s internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist ADCs for up to...
December 23, 2022 | News
The Notes are currently being offered and sold only to persons who are reasonably qualified institutional purchasers within the meaning of Rule 144A under ...
December 19, 2022 | News
Merck’s Millipore® CTDMO Services (Contract Testing, Development and Manufacturing Organization) to streamline viral vector development and pro...
December 14, 2022 | News
The dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023. Lilly unites caring with ...
December 13, 2022 | News
Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up Allows Merck t...
December 07, 2022 | News
Presently, most cancer diagnosis is done through thinly sliced physical biopsies. Though widespread, the amount of information this method collects remains...
December 06, 2022 | News
Drawing on more than 100 years of history as a trusted medical technology innovator1, GE Healthcare is closely connected with healthcare systems globally. ...
November 28, 2022 | News
Polytaxel, a novel pain-free anticancer drug, may not require break periods A new standard of care, more convenient than docetaxel, is suggest...
November 28, 2022 | News
AstraZeneca (Thailand) Co., Ltd., was recently honoured with two accolades in the categories of Industry Champions of the Year and Comm...
November 25, 2022 | News
Company aims to launch one new product or indication every 1.5 years on average, bolstered by external innovation Phase III assets xevinapant and evobru...
November 23, 2022 | News
Results of the third quarter of 2022 Group net sales rise by 16.8% to € 5.8 billion Strong organic sales growth of 7.1%, driven by the &...
November 14, 2022 | News
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, announced the commercial ava...
November 10, 2022 | News
Most Read
Bio Jobs
News